London 2014 Registration Visa Letters Programme Satellite Meetings Glaucoma Day 2014 Exhibition Hotel Booking Virtual Exhibition Star Alliance
london escrs

Course handouts are now available
Click here


Come to London

video-icon

WATCH to find out why


Site updates:

Programme Updates. Programme Overview and - Video Symposium on Challenging Cases now available.


Evaluating the safety and efficacy of phacoemulsification combined with CO2 laser-assisted sclerectomy surgery (CLASS)

Search Abstracts by author or title
(results will display both Free Papers & Poster)

Session Details

Session Title: Glaucoma II

Session Date/Time: Monday 15/09/2014 | 08:00-10:30

Paper Time: 08:25

Venue: Boulevard F (Level 1)

First Author: : R.Venkatesh INDIA

Co Author(s): :    S. Sengupta              

Abstract Details

Purpose:

To evaluate the safety and efficacy of phacoemulsification combined with CO2 Laser Assisted sclerectomy Surgery (CLASS) in patients with open-angle glaucoma.

Setting:

Aravind Eye Hospital, Pondicherry.

Methods:

A prospective, single-arm, non-randomized clinical trial. About 17 patients with Primary Open Angle Glaucoma (POAG) or Pseudoexfoliative Glaucoma (PEXG), baseline IOP >21 mmHg with or without anti-glaucoma medications were included. The surgery was performed through twin sites, initially a half- thickness rectangular scleral flap was created in the superior scleral area following which a phacoemulsification with IOL implantation was performed through the temporal clear corneal tunnel. After completion of cataract surgery a CO2 laser (“IOPtiMate”; IOPtima Ltd, Israel) was used to achieve deep scleral ablation and the end point of un-roofing of Schlemm’s Canal confirmed by fluid percolation was performed in all patients. Intraocular pressure (IOP) was measured at baseline and during follow-up visits. Complete and Qualified success rates were defined as 5≤IOP≤18 mm Hg without or with one medication, respectively.

Results:

The pre-operative IOP of 29.0 ± 12.3 mm Hg (mean ± SD) reduced to 14.6 ± 4.3 mm Hg at 12 months (n=17, p=0.0001, paired t test) and 13.0 ± 2.2 mm Hg at 24 months postoperatively (n=4, p=0.08). The Complete Success rate after 12 months was 70.5%, whereas Qualified Success was seen in another 17.6 %. Mitomycin C was used in 88% of the subjects.

Conclusions:

This study demonstrates that phacoemulsification combined with CLASS is a simple, safe, and effective technique for treating patients with open-angle glaucoma. Using a CO2 laser allows precise and easy ablation of the deep scleral space and delicate dissection of Schlemm’s canal and Descemet’s membrane.

Financial Interest:

NONE

Back to previous